• Help and guidance
  • Chatbot

The Healthcare Innovation Accelerator

An exclusive program designed to help companies redefine their market strategy.

HIA AEM

DNB//Back Bay is proud to introduce the new Healthcare Innovation Accelerator program in collaboration with Innovation Norway, Mayo Clinic Innovation Exchange and Destination Medical Center.

The Norwegian government´s national export strategy aims to increase exports in selected industries with healthcare being one of them. The U.S. is one of the main markets for Norwegian innovative healthcare companies, and the accelerator is dedicated to scaling healthcare companies and bridge the Norwegian and U.S. markets.

Experts from Aleap, Advokatfirmaet Thommessen, Sopra Steria, Onsagers and Patentstyret (Norwegian Industry Property Office) will provide the participants in the accelerator program with valuable insights into common challenges and unwanted surprises and how to solve or avoid them. Ergo-ego will teach the participants pitching techniques and how to tackle performance on stage.

Healthcare innovation Accelerator

Healthcare Innovation Accelerator program

See the selected companies for the Healthcare Innovation Accelerator 2024/2025.

The process

Norwegian digital health and MedTech companies with global ambitions, were invited to apply for the Healthcare Innovation Accelerator. This exclusive program is designed to help companies refine their market strategy and establish critical connections in the United States.

This is an opportunity to expand the company´s business into the world’s largest healthcare sector.

Who can apply?

  • Norwegian digital health and Medtech companies with a proven MVP or prototype.
  • Businesses ready for global expansion and eager to break into the U.S. market.

Key Dates:

  • Application Deadline: 18th October 2024.
  • Programme Launch: 26th November 2024 in Oslo.
  • Visit to New York: 24th–28th March 2025.

What selected companies can expect

Tone Varslot Stave

Tone Varslot Stave
Head of health export
Innovation Norway

"Building a program for Norwegian early-stage companies is well in line with Innovation Norway's general mission."
Says Tone Varslot Stave in Innovation Norway

Trine Loe

Trine Loe
Global Head of Future & Tech Industries
DNB Bank ASA

"The program will help you fine-tune your marketing strategy for the U.S. and establish important contacts. This year, the accelerator program will specifically target early-stage medtech and digital health companies, and large parts of the programme will target the U.S. market."
Says Trine Loe in DNB

Footer navigation

Head office

Dronning Eufemias gate 30

0191 Oslo, Norway

Postal address

DNB

PO Box 1600 - Sentrum

0021 Oslo

Org. no.

DNB Bank ASA

984 851 006

DNB Websites

DNB Eiendom (DNB Real Estate)#girlsinvestDNB Tech Blog

International

DNB LuxembourgDNB SwedenDNB Denmark

Social media

Terms of useData protectionCookiesPrice listCompare our prices with other companies at Finansportalen.noWork for us

© DNB